Answers are grounded in this paper and cite their sources.
Accelerated PACK-CXL was successfully used as a first-line and sole treatment in a case of early fungal keratitis caused by Aureobasidium pullulans. Further characterization of the antifungal effect of PACK-CXL is needed in prospective studies.
No takes yet. Share an insight, caveat, or question.
Tabibian et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: